Venus Remedies Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26
Revenue	195	132	193	180	259
Other income	7	9	2	3	5
Expenses	171	128	168	149	203
Cost of materials consumed	104	71	107	94	116
Purchases of stock-in-trade	2	2	2	2	5
Change in inventories	-3	0.60	-1	-10	-1
Employee benefit expense	21	20	23	21	25
Depreciation & amortisation	5	6	6	7	7
Other expenses	42	27	32	36	52
EBITDA	36	19	33	40	68
EBIT	31	13	27	34	62
Profit Before Tax	31	13	27	34	62
Tax expense	7	3	6	8	14
Deferred tax	2	-0.70	-0.10	-0.40	-0.40
Net Profit	21	10	20	26	48
Financial Ratios
Operating Profit Margin	15.90%	9.55%	13.73%	18.61%	23.78%
EBITDA Margin	18.31%	14.24%	16.94%	22.28%	26.41%
Net Profit Margin	10.77%	7.27%	10.41%	14.22%	18.34%
Earnings Per Share (₹)	15.71	7.18	15.06	19.14	35.53

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.